InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Browse the complete record of transactions filed by Semigran Marc, Directeur Médical. Officer active across 2 companies, notably Renovacor, Inc.. In total, 3 reports have been published. History available since 24 January 2022. The latest transaction was disclosed on 24 December 2024 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 条申报中的 3 条
Marc Semigran is the Chief Medical Officer of Renovacor, Inc. In this role, he oversees the medical and clinical initiatives of the company, which focuses on developing innovative therapies. With a strong background in the medical field, he plays a crucial role in the research and development strategy of Renovacor, Inc.